Identifying Alcohol Use Disorder in Patients With Cirrhosis Reduces 30-Days Readmission Rate. (11th May 2022)

• Record Type: Journal Article
• Authors: Singal, Ashwani K; DiMartini, Andrea; Leggio, Lorenzo; Arab, Juan P; Kuo, Yong-Fang; Shah, Vijay H
• Is Part Of: Alcohol and alcoholism. Volume 57:Number 5(2022)
• Page Start: 576
• Page End: 580
• Publication Date: 2022-05-11
• Subjects: Alcoholism -- Periodicals; 616.861005
• DOI: 10.1093/alcalc/agac015
• Languages: English
• ISSNs: 0735-0414

Abstract

Abstract: Aims: Readmission is frequent among patients with cirrhosis and is a complex multifactorial process. To examine the association of alcohol use disorder (AUD) and risk of readmission in patients with alcohol-associated cirrhosis. Methods and Results: National Readmission Dataset (2016–2017) was used to extract a retrospective cohort of 53, 348 patients with primary or secondary discharge diagnosis code of alcohol-associated cirrhosis with their first admission (26, 674 patients with vs. propensity matched 26, 674 without a primary or secondary discharge diagnosis code of AUD). Readmission within 30-day was lower (43.9 vs. 48%, P < 0.001) among patients identified to have AUD at the time of discharge. In a conditional logistic regression model, a diagnosis of AUD was associated with 15% reduced odds of 30-day readmission, 0.85 (0.83–0.88). Furthermore, the reason for readmission among patients identified vs. not identified to have AUD was less likely to be liver disease complication. The findings remained similar in a matched cohort of patients where the AUD diagnosis at discharge was listed as one of the secondary diagnoses only. Conclusion: Although, our study findings suggest that identification of AUD at the time of discharge among patients hospitalized for alcohol-associated cirrhosis reduces the risk of 30-day readmission, unavailable information on patient counseling, referral for mental health specialist and treatment received for AUD limit the causality assessment. Future studies are needed overcoming the inherent limitations of the database to establish the role of identification and treatment of AUD in reducing readmission and liver decompensation in patients with alcohol-associated cirrhosis.